Dasatinib as 2nd line treatment is safe and effective in peruvian CML patients: A multicentric real-world study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Cesar Augusto Samanez Figari, Marlies Pizarro-Perea, Víctor Mallma, Guillermo Valladares, Victor Seminario, Susy Bazán Ruiz, Laura Chávez, Maria Vera, Gledy Jimenez Tornero, Estefany Menacho, Marcos Heredia-Vallejos, Cindy Calle, Claudia Castillo, Jorge Sánchez, Mayra Victoria Mariscal Huamani, Camila Amado Rottier, Olga Vargas, Jose Untama
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417010047
Cites:
Cited by:
Related to: